Changes in hematological variables and globular sedimentation rate in non-critical patients withCOVID-19
Keywords:
COVID-19, EPIDEMIOLOGIC FACTORS, PATIENT, HEMATOLOGY, LABORATORY TEST.Abstract
Introduction: clinical hematology tests and globular sedimentation rate (ESR) have been used as markers of clinical evolution in patients with thenovel coronavirus disease 2019.
Objective: to analyze changes in hematological variables and ESR in patients diagnosed with COVID-19 in non-critical status, admitted to Dr. León Cuervo Rubio Provincial Clinical-surgical Teaching Hospital, between March 16 and May 4, 2020.
Methods: an observational-analytical and longitudinal-prospective study conducted with data from 44 non-critical patients with COVID-19. Samples were examined for: hemoglobin, hematocrit, global leukocyte count, neutrophils, lymphocytes, medium size cells and erythrocyte sedimentation rate; on admission, at 48hours of admission, on the eighth day and on medical discharge. The longitudinal changes of these variables were analyzed by means of the non-parametric Friedman test for k-related samples.
Results: hematological variables: hemoglobin, hematocrit, global leukocyte count, neutrophils and lymphocytes did not have significant changes during the follow up. Only medium size cells decreased significantly in children, when comparing their mean value at discharge in relation to admission (p=0,028) and on the second day of hospitalization (p=0,01). In adult male patients, the ESR significantly decreased at eighth day of admission and at medical discharge, in relation to its value at admission (p=0,008).
Conclusions: the changes observed in the hematological variables assessed, especially in the medium size cellsin children, and erythrocyte sedimentation rate in men with COVID-19 in non-critical status, respond to a favorable clinical evolution.
Downloads
References
1. Zhu N, Zhang D, Wang W, Li X, Yang B et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med [Internet]. 2020 Feb [citado 19/5/2020]; 382(8): [aprox. 6p.]. Disponible: https://www.nejm.org/doi/full/10.1056/NEJMoa2001017
2. WHO. Coronavirus disease (COVID-19) pandemic [Internet]. WHO; 2020. [actualizado 24 May 2020; citado 25/05/2020]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
3. Corman VM, Landt O, Kaiser M, Kaiser M, Molenkamp R. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Rev Eur Surveill [Internet]. 2020 Ene 25 [citado 19/5/2020]; 25(3): [aprox. 8p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988269/
4. Eugene B, Lian VC, Seok S, Hsiang G, Hsiang S. Hematologic parameters in patients with COVID-19 infection. AJH [Internet]. 2020 Ene 25 [citado 20/5/2020]; 95(6): [aprox. 5p.]. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.25774
5. Lapic I, Rogic D, Plebani M. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis. Clin Chem Lab Med [Internet]. 2020 May [citado 20/5/2020]; 58(7): [aprox. 2p.]. Disponible en: https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0620/article-10.1515-cclm-2020-0620.xml
6. Frater JR, Zini G, d’Onofrio G, Rogers HJ. COVID-19 and the clinical hematology laboratory. ISLH [Internet]. 2020 Abr [citado 21/5/2020]; 42(s1): [aprox. 7p.]. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/ijlh.13229
7. Misnisterio de Salud Pública. Protocolo de actuación nacional para la covid-19. (Versión provisional para uso del personal de salud que labora en el enfrentamiento a los casos) Versión 1.4. [Internet]. Infomed; Abril 2020 [actualizado Abr 2020; citado 23/05/2020] Disponible:http://www.sld.cu/anuncio/2020/05/11/ministerio-de-salud-publica-protocolo-de-actuacion-nacional-para-la-covid-19
8. Sociedad Cubana de Patología Clínica [Internet]. Cuba: Infomed; 2020 [actualizado 19 May 2020; citado 20/05/2020]. Disponible en: http://www.sld.cu/uvs/patologiaclinica/
9. García de Lorenzo Mateos A, Quintana Díaz M. Aspectos hematológicos en la sepsis grave. REMI [Internet]. 2004 Abr [citado 20/05/2020]; 4(12). Disponible: https://remi.uninet.edu/2004/12/REMIC20.htm
10. Wenzhong L, Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. Rev Chem R xiv [Internet]. 2020 Abr 13 [citado 21/5/2020]; 26(7): [aprox. 23p.]. Disponible en: https://chemrxiv.org/articles/COVID-19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173
11.Zhang H, Wang X, Fu Z, Luo M, Zhang Z. Potential Factors for Prediction of Disease Severity of COVID-19 Patients. Med Rxiv [Internet]. 2020 Mar [citado 19/05/2020]. Disponible en: https://www.medrxiv.org/content/10.1101/2020.03.20.20039818v1
12. Didangelos A. Neutrophil involvement in Covid-19. Preprint [Internet]. 2020 Abr [citado 19/05/2020]: [aprox. 5p.]. Disponible: https://www.preprints.org/manuscript/202004.0363/v2
13. Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med [Internet]. 2020 Jun 25 [citado 12/5/2020]; 58(7): [aprox. 4p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32172227/
14. Mozzini Ch, Girelli D. The role of Neutrophil Extracellular Traps in Covid-19: only an hypothesis or a potential new field of research? Thromb Res [Internet]. 2020 Jul [citado 24/5/2020]; 191: [aprox. 1p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184981/
15. Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nad Rev Im [Internet]. 2020 May [citado 21/5/2020]; 20(6): [aprox. 7p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32376901/
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/